Device makers, like pharmaceutical manufacturers, have long recognized that their success depends upon making their products known to physicians who will prescribe or recommend the use of their particular product.
In addition to their ability to influence current product use, physicians also are in the best position to conduct or oversee research that may expand future market share, including identifying additional clinical uses or adaptations for a product — some of which may not yet be approved by the U.S. Food and Drug Administration (FDA).
Read the complete article by clicking on the link below.
Reprinted with permission from Portfolio Media, Inc. This appeared in both Health Law360 and Competition Law360.
Author(s)
Related Insights
23 May 2025
Tariff & International Trade Resource
Oscar the Grouchy CCO
This Memorial Day marks 35 years since Jim Henson, creator of the Muppets, passed away. Among his many accomplishments, the Muppets were essential to the creation of the longest-running children’s television show, “Sesame Street,” which has been airing for over 55 years.
03 June 2025
Events
FO PRO: ALIGN: Connecting the Family and the Family Office
Foley partner, Nate Imfeld, and senior counsel, Nicholas Chamis, will be speaking at the upcoming ALIGN Conference, hosted by Family Business Magazine in Chicago, Illinois. They will be hosting the breakout session, Sports Teams, AI, Bitcoin and More.
04 June 2025
Events
Health Care Organizations: Reduce Cybersecurity Threats
Foley partner Jennifer Urban, chair of the firm’s Cybersecurity & Data Privacy Area of Focus, is speaking in Moss Adams’ upcoming webinar titled “Health Care Organizations: Reduce Cybersecurity Threats” on June 4.